Results 181 to 190 of about 15,050 (215)

MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants With nAMD and Persistent Retinal Fluid.

Ophthalmology (Rochester, Minn.), 2022
A. Khanani, David M. Brown, G. Jaffe, C. Wykoff, Eser Adiguzel, Randall Wong, Xiangyi Meng, J. Heier   +7 more
semanticscholar   +1 more source

Intravitreal brolucizumab for nAMD - real-world data.

2023
Purpose To present the real world outcomes of brolucizumab treatment for nAMD Methods A single center retrospective study of 407 consecutive patients 57 5 female, mean age at first application 76 2 8 4 years, with no group differences) with neovascular age related macular degeneration ( treated with brolucizumab 6 mg/ 0 05 mL) intravitreally from April
Predović, Jurica, Martinčević, Dora
openaire  

Supporting NAMD Application on the Grid Using GPE

2008
Molecular simulations are playing important role in understanding the mechanisms at microscopic level of all organisms. Increasing computer power available at single computers is still not enough for the molecular simulations. In this case, the grid middleware which has the ability to distribute calculations in a seamless and secure way over different ...
Rafał Kluszczyński, Piotr Bała
openaire   +1 more source

Lange Therapieintervalle bei nAMD

Kompass Ophthalmologie, 2022
openaire   +1 more source

NAMD: A case study in multilingual parallel programming

1998
Parallel languages are tools for constructing efficient application programs, while reducing the required labor. In this light, using the most appropriate tool for each component of a complex system seems natural, resulting in multi-paradigm multilingual programming.
L. V. Kalé, M. Bhandarkar, R. Brunner, N. Krawetz, J. Phillips, A. Shinozaki   +5 more
openaire   +1 more source

NUMERICAL MODELING FOR MECHANICAL PROPERTIES OF Namd(TM) CFRP

2019
Namd(TM) CFRP (that is CFRP including carbon nanotube) was developed by NITTA CORPORATION. Interfacial toughness of Namd(TM) CFRP laminates is about 30% greater than that of conventional CFRP laminates.
Satoshi Tomita, Jun Koyanagi, Takuji Komukai, Toshikazu Uno   +3 more
openaire   +1 more source

Implementation of PaDSAR method on NAMD

Pseudoatoms Driven Solvent Accessibility Refinement or PaDSAR is a computational approach for modeling low-resolution membrane protein structure using restraints derived from the solvent accessibility data from site-directed spin labelling and electron paramagnetic resonance spectroscopy.
openaire   +1 more source

NAnoscale Molecular Dynamics (NAMD)

2011
Laxmikant V. Kalé, Abhinav Bhatele, Eric J. Bohm, James C. Phillips, David H. Bailey, Ananth Y. Grama, Joseph Fogarty, Hasan Aktulga, Sagar Pandit, David Padua, Hiroshi Takahara, Guy Blelloch, Robert Latham, Holger Fröning, Kieran T. Herley, David Padua, Olav Lysne, Frank Olaf Sem-Jacobsen, Marı́a Engracia Gómez Requena, Olav Lysne, Frank Olaf Sem-Jacobsen, Danny Hendler, Alessandro Bardine, Pierfrancesco Foglia, Cosimo Antonio Prete, Marco Solinas, Michael Garland, N. Govind, Eric J. Bylaska, Wibe A. Jong, K. Kowalski, Tjerk P. Straatsma, Marat Valiev, H. van J. J. Dam   +33 more
openaire   +1 more source

NAMD (NAnoscale Molecular Dynamics)

2011
Laxmikant V. Kalé, Abhinav Bhatele, Eric J. Bohm, James C. Phillips, David H. Bailey, Ananth Y. Grama, Joseph Fogarty, Hasan Aktulga, Sagar Pandit, David Padua, Hiroshi Takahara, Guy Blelloch, Robert Latham, Holger Fröning, Kieran T. Herley, David Padua, Olav Lysne, Frank Olaf Sem-Jacobsen, Marı́a Engracia Gómez Requena, Olav Lysne, Frank Olaf Sem-Jacobsen, Danny Hendler, Alessandro Bardine, Pierfrancesco Foglia, Cosimo Antonio Prete, Marco Solinas, Michael Garland, N. Govind, Eric J. Bylaska, Wibe A. Jong, K. Kowalski, Tjerk P. Straatsma, Marat Valiev, H. van J. J. Dam   +33 more
openaire   +1 more source

Real world efficacy and durability of faricimab in patients with neovascular AMD (nAMD) who had sub-optimal response to prior anti-VEGF therapy

Eye
Christine Goodchild, Clare Bailey, Jimena Soto Hernaez, E. Ahmed, S. Salvatore   +4 more
semanticscholar   +1 more source